Assay Biomarker secures $0.07 million in funding - MarketLine Financial Deals

Assay Biomarker secures $0.07 million in funding

Assay Biomarker secures $0.07 million in funding - MarketLine Financial Deals
Assay Biomarker secures $0.07 million in funding
Published Sep 10, 2012
2 pages — Published Sep 10, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Assay Biomarker, Inc., a biotech company developing disease-specific biomarker antibodies and related products, has secured $0.075 million investment from The Maryland Technology Development Corporation (TEDCO).

  
Source:
Document ID
MA139305_130524
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Assay Biomarker secures $0.07 million in funding" Sep 10, 2012. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Assay-Biomarker-secures-0-07-million-in-funding-2052-94838>
  
APA:
MarketLine Financial Deals. (2012). Assay Biomarker secures $0.07 million in funding Sep 10, 2012. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Assay-Biomarker-secures-0-07-million-in-funding-2052-94838>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.